» Articles » PMID: 32192230

Steady-State Kinetics of Enzyme-Catalyzed Hydrolysis of Echothiophate, a P-S Bonded Organophosphorus As Monitored by Spectrofluorimetry

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2020 Mar 21
PMID 32192230
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Enzyme-catalyzed hydrolysis of echothiophate, a P-S bonded organophosphorus (OP) model, was spectrofluorimetrically monitored, using Calbiochem Probe IV as the thiol reagent. OP hydrolases were: the G117H mutant of human butyrylcholinesterase capable of hydrolyzing OPs, and a multiple mutant of phosphotriesterase, GG1, designed to hydrolyze a large spectrum of OPs at high rate, including V agents. Molecular modeling of interaction between Probe IV and OP hydrolases (G117H butyrylcholinesterase, GG1, wild types of and phosphotriesterases, and human paraoxonase-1) was performed. The high sensitivity of the method allowed steady-state kinetic analysis of echothiophate hydrolysis by highly purified G117H butyrylcholinesterase concentration as low as 0.85 nM. Hydrolysis was michaelian with = 0.20 ± 0.03 mM and = 5.4 ± 1.6 min. The GG1 phosphotriesterase hydrolyzed echothiophate with a high efficiency ( = 2.6 ± 0.2 mM; = 53400 min). With a = (2.6 ± 1.6) × 10 Mmin, GG1 fulfills the required condition of potential catalytic bioscavengers. quantum mechanics/molecular mechanics (QM/MM) and molecular docking indicate that Probe IV does not interact significantly with the selected phosphotriesterases. Moreover, results on G117H mutant show that Probe IV does not inhibit butyrylcholinesterase. Therefore, Probe IV can be recommended for monitoring hydrolysis of P-S bonded OPs by thiol-free OP hydrolases.

Citing Articles

Ultrahigh-Throughput Directed Evolution of a Metal-Free α/β-Hydrolase with a Cys-His-Asp Triad into an Efficient Phosphotriesterase.

Schnettler J, Klein O, Kaminski T, Colin P, Hollfelder F J Am Chem Soc. 2022; 145(2):1083-1096.

PMID: 36583539 PMC: 9853848. DOI: 10.1021/jacs.2c10673.


Kinetic Processes in Enzymatic Nanoreactors for In Vivo Detoxification.

Shajhutdinova Z, Pashirova T, Masson P Biomedicines. 2022; 10(4).

PMID: 35453533 PMC: 9025091. DOI: 10.3390/biomedicines10040784.


Enzymatic Decontamination of G-Type, V-Type and Novichok Nerve Agents.

Jacquet P, Remy B, Bross R, van Grol M, Gaucher F, Chabriere E Int J Mol Sci. 2021; 22(15).

PMID: 34360916 PMC: 8347808. DOI: 10.3390/ijms22158152.


Enzymes, Reacting with Organophosphorus Compounds as Detoxifiers: Diversity and Functions.

Lyagin I, Efremenko E Int J Mol Sci. 2021; 22(4).

PMID: 33578824 PMC: 7916636. DOI: 10.3390/ijms22041761.


1-(3--Butylphenyl)-2,2,2-Trifluoroethanone as a Potent Transition-State Analogue Slow-Binding Inhibitor of Human Acetylcholinesterase: Kinetic, MD and QM/MM Studies.

Zueva I, Lushchekina S, Pottie I, Darvesh S, Masson P Biomolecules. 2020; 10(12).

PMID: 33260981 PMC: 7760592. DOI: 10.3390/biom10121608.

References
1.
Bigley A, Xu C, Henderson T, Harvey S, Raushel F . Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis. J Am Chem Soc. 2013; 135(28):10426-32. PMC: 3747228. DOI: 10.1021/ja402832z. View

2.
Kumar A, Darreh-Shori T . DMSO: A Mixed-Competitive Inhibitor of Human Acetylcholinesterase. ACS Chem Neurosci. 2017; 8(12):2618-2625. DOI: 10.1021/acschemneuro.7b00344. View

3.
Kowalczewska M, Fenollar F, Villard C, Azza S, Roux M, Raoult D . An immunoproteomic approach for identification of clinical biomarkers of Whipple's disease. Proteomics Clin Appl. 2010; 2(4):504-16. DOI: 10.1002/prca.200780078. View

4.
Goldsmith M, Ashani Y . Catalytic bioscavengers as countermeasures against organophosphate nerve agents. Chem Biol Interact. 2018; 292:50-64. DOI: 10.1016/j.cbi.2018.07.006. View

5.
Worek F, Thiermann H, Wille T . Catalytic bioscavengers in nerve agent poisoning: A promising approach?. Toxicol Lett. 2015; 244:143-148. DOI: 10.1016/j.toxlet.2015.07.012. View